Agios Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Oct '25 Oct 17, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	1,836	1,497	977	1,280	1,318	2,198	Upgrade
Market Cap Growth	4.24%	53.19%	-23.69%	-2.87%	-40.02%	-10.83%	Upgrade
Enterprise Value	867	219	352	504	360	1,937	Upgrade
Last Close Price	32.29	26.32	17.50	25.51	24.92	32.40	Upgrade
PE Ratio	3.87	2.78	-	-	1.11	-	Upgrade
PS Ratio	61.53	51.35	46.40	108.35	-	-	Upgrade
PB Ratio	1.84	1.22	1.54	1.40	1.38	7.51	Upgrade
P/TBV Ratio	1.84	1.22	1.54	1.40	1.38	7.51	Upgrade
EV/Sales Ratio	28.25	7.51	16.70	42.61	-	-	Upgrade
EV/FCF Ratio	-2.90	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.04	0.04	0.09	0.08	0.08	0.26	Upgrade
Asset Turnover	0.04	0.03	0.03	0.01	-	-	Upgrade
Inventory Turnover	11.86	13.08	21.65	-	-	-	Upgrade
Quick Ratio	13.41	11.06	11.49	12.54	17.17	6.07	Upgrade
Current Ratio	14.48	11.90	12.27	13.30	17.79	6.75	Upgrade
Return on Equity (ROE)	64.05%	57.29%	-36.83%	-19.38%	-42.15%	-63.33%	Upgrade
Return on Assets (ROA)	-25.71%	-20.47%	-22.49%	-18.17%	-20.65%	-24.08%	Upgrade
Return on Capital (ROIC)	-26.91%	-21.45%	-23.65%	-18.88%	-24.98%	-33.35%	Upgrade
Earnings Yield	25.85%	35.95%	-28.29%	-15.02%	89.89%	-10.91%	Upgrade
FCF Yield	-16.26%	-20.89%	-23.87%	-20.38%	-23.14%	-10.16%	Upgrade
Buyback Yield / Dilution	-3.93%	-4.02%	-1.57%	9.36%	12.39%	-15.01%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.